Literature DB >> 18812024

An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicity.

Kasiram Katneni1, Susan A Charman, Christopher J H Porter.   

Abstract

The roles of the unstirred water layer (UWL) and receptor sink on the in-vitro transmembrane permeability of an increasingly lipophilic series of compounds (mannitol (MAN), diazepam (DIA) and cinnarizine (CIN)) have been assessed. Altered carbogen bubbling rates were used as a means to change the UWL thickness and polysorbate-80 (PS-80), bovine serum albumin (BSA) and alpha-1-acid glycoprotein (AAG) were employed to alter sink conditions. After correction for solubilisation, Papp data for MAN, DIA and CIN were consistent across varying donor PS-80 concentrations suggesting that for the drugs examined here, the donor UWL did not limit in-vitro permeability. Similarly, altered bubbling rates and receptor sink conditions had no impact on the permeability of MAN. In contrast, decreasing the size of the receptor UWL or adding solubilising agents to the receptor sink resulted in modest enhancements to the permeability of the more lipophilic probe DIA. For the most lipophilic compound, CIN, very significant changes to measured permeability (>30 fold) were possible, but were most evident only after concomitant changes to both the UWL and sink conditions, suggesting that the effectiveness of enhanced sink conditions were dependent on a decrease in the width of the UWL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812024     DOI: 10.1211/jpp/60.10.0007

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.

Authors:  Isabel Lozoya-Agullo; Isabel Gonzalez-Alvarez; Moran Zur; Noa Fine-Shamir; Yael Cohen; Milica Markovic; Teresa M Garrigues; Arik Dahan; Marta Gonzalez-Alvarez; Matilde Merino-Sanjuán; Marival Bermejo; Alex Avdeef
Journal:  Pharm Res       Date:  2017-12-29       Impact factor: 4.200

2.  Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.

Authors:  Zhiwen Yang; Yinhe Tan; Meiwan Chen; Linghui Dian; Ziyun Shan; Xinsheng Peng; Chuanbin Wu
Journal:  AAPS PharmSciTech       Date:  2012-10-23       Impact factor: 3.246

3.  Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles.

Authors:  Jie Lai; Yi Lu; Zongning Yin; Fuqiang Hu; Wei Wu
Journal:  Int J Nanomedicine       Date:  2010-02-02

4.  Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies.

Authors:  Xin Jin; Zhen-hai Zhang; E Sun; Xiao-bin Tan; Song-lin Li; Xu-dong Cheng; Ming You; Xiao-bin Jia
Journal:  Int J Nanomedicine       Date:  2013-02-12

5.  Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study.

Authors:  Linghui Dian; Zhiwen Yang; Feng Li; Zhouhua Wang; Xin Pan; Xinsheng Peng; Xintian Huang; Zhefei Guo; Guilan Quan; Xuan Shi; Bao Chen; Ge Li; Chuanbin Wu
Journal:  Int J Nanomedicine       Date:  2013-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.